Delivery Order SPE2DB22D3301-SPE2DB25FY1DR

Award Date 3/7/25
Potential Completion Date 3/10/25
Potential Value $19K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,127.68 firm fixed-price delivery order is for the supply of Tetracaine 0.5% Steri-Unit Solution, a topical anesthetic medication. The contract has an ultimate completion date of March 6, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a federal contract award issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,960.76, is for the delivery of Tetracaine 0.5% Eye 1s, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and an ultimate completion date of November 8, 2024. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,351.05 firm fixed-price delivery order is for the supply of 4558843937 - TETRACAINE 0.5% STERI-UNIT SOL 4ML. The contract has an ultimate completion date of October 24, 2022 and was awarded on October 21, 2022. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $2,773.35, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TETRACAINE 0.5% STERI-UNIT SOL 4ML, a medical product. It is a firm fixed-price delivery order contract with a completion date of February 3, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,201.73 firm fixed-price delivery order is for the supply of Tetracain HCL 0.5% 12S, a pharmaceutical product. The contract has a performance period through May 21, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the supply of Tetracaine 0.5% Steri-Unit Solution, a prescription medication. The contract is a delivery order with a firm fixed price of $1,052.91 and a completion date of May 29, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,364.96, is for the delivery of 4565555928 - Tetracain HCL 0.5% 12S, a medical product. The contract is a Firm Fixed Price Delivery Order with a completion date of September 20, 2024. This award is a part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Tetracaine 0.5% Steri-Unit Solution (4 ml). The $1,883.35 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA) on February 23, 2022, with a completion date of February 24, 2022. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which has a significant $999,999,999...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order valued at $8,099.51 for the supply of TETRACAINE 0.5% STERI-UNIT SOL 4ML, a pharmaceutical product. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical, a division of the Department of Defense, and has an ultimate completion date of April 17, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,134.50, is a firm fixed-price delivery order for the supply of 4,566,374,137 units of 0.5% Tetracaine Steri-Unit Solution in 4 ml vials. The contract has a completion date of November 8, 2024 and was awarded on November 7, 2024. No set-aside requirements were specified for this award....
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB25FY1DR
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, with a ceiling value of $19,142.85, is for the delivery of Tetracaine 0.5% Steri-Unit Solution, a medication used for local anesthesia. The contract is a Firm Fixed Price Delivery Order with a completion date of March 10, 2025.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.

The contract award did not have a set-aside designation, indicating open competition.

Generated 6/6/25, 9:58 AM